Skip to main content
Premium Trial:

Request an Annual Quote

Evorion: Christian Scheiner, Helge Lubenow, Oliver Schacht, Steffen Bersch

Evorion Biotechnologies, a German developer of a high-content, single-cell assay system for functional phenomics, has appointed Christian Scheiner, Helge Lubenow, Oliver Schacht, and Steffen Bersch to its inaugural supervisory board.

Scheiner is CEO at Cilian, and has more than three decades of experience in the pharmaceutical and biotechnology industries. Lubenow is CEO at Proteomedix and has extensive experience in cancer diagnostics, personalized medicine, and clinical research. Schacht is president and CEO at OpGen, and has experience as a corporate finance executive in the molecular diagnostics industry. Bersch is CEO at SSI Schäfer Group, and has more than 15 years of experience specializing in corporate business development and governance.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.